Meningococcal disease and complement. 1989

D L Gordon

UI MeSH Term Description Entries
D008403 Mass Screening Organized periodic procedures performed on large groups of people for the purpose of detecting disease. Screening,Mass Screenings,Screening, Mass,Screenings,Screenings, Mass
D008589 Meningococcal Infections Infections with bacteria of the species NEISSERIA MENINGITIDIS. Meningococcal Septicemia,Infections, Meningococcal,Meningococcal Disease,Infection, Meningococcal,Meningococcal Diseases,Meningococcal Infection,Septicemia, Meningococcal
D003165 Complement System Proteins Serum glycoproteins participating in the host defense mechanism of COMPLEMENT ACTIVATION that creates the COMPLEMENT MEMBRANE ATTACK COMPLEX. Included are glycoproteins in the various pathways of complement activation (CLASSICAL COMPLEMENT PATHWAY; ALTERNATIVE COMPLEMENT PATHWAY; and LECTIN COMPLEMENT PATHWAY). Complement Proteins,Complement,Complement Protein,Hemolytic Complement,Complement, Hemolytic,Protein, Complement,Proteins, Complement,Proteins, Complement System
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

D L Gordon
October 1991, Clinical and experimental immunology,
D L Gordon
January 1993, Immunologic research,
D L Gordon
January 2014, Virulence,
D L Gordon
September 1983, The New England journal of medicine,
D L Gordon
March 2006, The Pediatric infectious disease journal,
D L Gordon
January 2001, Methods in molecular medicine,
D L Gordon
June 1993, Nederlands tijdschrift voor geneeskunde,
D L Gordon
March 2002, Archives of disease in childhood,
D L Gordon
April 1976, British medical journal,
D L Gordon
July 1989, The Journal of infectious diseases,
Copied contents to your clipboard!